Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
…
3,075€
-0,16%
Echtzeit-Aktienkurs Emergent Biosolutions Inc.
Bid:
Ask:
Nachrichten zur Emergent Biosolutions Inc. Aktie
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
EBS earnings call for the period ending March 31, 2024.…
Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
…
Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Emergent BioSolutions Reports First Quarter 2024 Financial Results
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the results of…
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into…
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and…
Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%
The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
EBS earnings call for the period ending December 31, 2023.…
Emergent BioSolutions Inc. (EBS) Q4 2023 Earnings Call Transcript
…
Emergent BioSolutions Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
Emergent BioSolutions appoints new CEO to drive growth By Investing.com
Emergent BioSolutions appoints new CEO to drive growth…
Emergent BioSolutions extends shelf life of Narcan to 4 years
…
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that…
Emergent BioSolutions stock pulls back, after rallying last week in wake of Biden administration’s endorsement of overdose medications
…
Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
…
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
The BARDA is exercising an option to procure additional doses of Emergent BioSolutions (EBS) recently approved anthrax vaccine. Deliveries will…
Emergent BioSolutions faces NYSE non-compliance over delayed Q3 filing By Investing.com
Emergent BioSolutions faces NYSE non-compliance over delayed Q3 filing…
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November…
SNGX: Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperature…
By David Bautz, PhD
NASDAQ:SNGX
READ THE FULL SNGX RESEARCH REPORT
Business Update
Filovirus Vaccine Candidates Demonstrate Two-Year Stability at Elevated Temperatures
In September 2023,…
Emergent Biosolutions reports Q3 results; updates FY23 guidance
…
Emergent BioSolutions Inc. 2023 Q3 - Results - Earnings Call Presentation
…
Emergent BioSolutions Inc. (EBS) Q3 2023 Earnings Call Transcript
…
Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript
EBS earnings call for the period ending September 30, 2023.…
Emergent BioSolutions Reports Third Quarter 2023 Financial Results
GAITHERSBURG, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported selected financial results…
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023
GAITHERSBURG, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) has rescheduled its conference call…
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023
GAITHERSBURG, Md., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call…
SHAREHOLDER ALERT: Morris Kandinov Investigating EBS, JRVR, EGIO, and HAFC; Shareholders are Encouraged to Contact the Firm
SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- National law firm Morris Kandinov is investigating the actions of…
Why Emergent BioSolutions Stock Is Tumbling Today
The healthcare stock will soon be booted from an index tracked by several ETFs....…
Stocks to Watch: Emergent Biosolutions, ZW Data Action Technologies, Tingo Group, Dragonfly Energy
Stocks to Watch: Emergent Biosolutions, ZW Data Action Technologies, Tingo Group, Dragonfly Energy...…
Emergent Biosolutions Shares Fall 5%; Company to Exit SmallCap 600
Emergent Biosolutions Shares Fall 5%; Company to Exit SmallCap 600...…
Form 8-K Emergent BioSolutions For: Aug 11
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript
EBS earnings call for the period ending June 30, 2023....…
Emergent Biosolutions (EBS) Reports Q2 Loss, Tops Revenue Estimates
Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -8.16% and 59.20%, respectively, for the quarter ended June 2023. Do…
2023 Layoff Tracker: Tyson Foods, Emergent BioSolutions Cut Hundreds Of Jobs
Layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter of 2023....…
Emergent Biosolutions Non-GAAP EPS of -$1.06 misses by $0.43, revenue of $337.9M beats by $121.15M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Reports Financial Results for Second Quarter 2023
GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for…
2023 Layoff Tracker: Emergent BioSolutions Cuts 400 Jobs
Layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter of 2023....…
Emergent BioSolutions to cut 400 jobs, streamline operations
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions to lay off about 400 employees
...(Reuters) - Emergent BioSolutions Inc said on Tuesday it plans......…
UPDATE 1-Emergent BioSolutions to lay off about 400 employees
... (Reuters) - Emergent BioSolutions Inc said
on Tuesday it plans to lay off......…
Form 8-K Emergent BioSolutions For: Aug 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
Actions bring sharpened focus on MCM and NARCAN® Nasal Spray products...…
Why Emergent Biosolutions Stock Is Surging After The Close
Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher in Monday's after-hours session after the company was awarded a 10-year contract for…
Emergent BioSolutions up 8% on up to $704M Ebola contract
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Gets $704 Million Ebola Treatment Contract From the U.S.
Emergent BioSolutions Gets $704 Million Ebola Treatment Contract From the U.S....…
Form 8-K Emergent BioSolutions For: Jul 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola
GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was…